Alprolix 500 Unit (Recombinant Human Coagulation Factor Ix, Fc Fusion Protein KIT) 500 UNIT

ALPROLIX 500 Unit is a recombinant human coagulation factor IX, FC fusion protein used for hemophilia B treatment. This intravenous kit helps manage bleeding episodes and prevent complications.

Strength

500 UNIT

Manufacturer / TM Owner

SANOFI-AVENTIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ALPROLIX 500 Unit is primarily used for the control and prevention of bleeding episodes in patients with hemophilia B, a genetic disorder that affects blood clotting. It is designed to replace the missing clotting factor IX, which is essential for normal blood coagulation. This medication is often used in both routine prophylaxis and on-demand treatment to manage bleeding episodes effectively.

Side Effects

Common effects of ALPROLIX 500 Unit may include localized reactions at the injection site, such as redness, swelling, or discomfort. Some users might experience mild to moderate headaches or nausea. These effects are generally temporary and should subside as the body adjusts to the medication.

Precautions & Warnings

ALPROLIX 500 Unit should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow the healthcare provider's instructions for preparation and use. Patients with known allergies to any components of the medication should avoid its use. Always consult a healthcare professional before starting any new treatment.

Avoid Interactions

ALPROLIX 500 Unit may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking. Avoid using this medication with other blood thinners unless directed by a healthcare professional.

Frequently Asked Questions

ALPROLIX 500 Unit is used to manage and prevent bleeding episodes in patients with hemophilia B.

ALPROLIX 500 Unit is administered intravenously, typically by a healthcare professional or trained caregiver.

Common side effects may include localized reactions at the injection site, headaches, and nausea.

It is important to consult a healthcare provider before using ALPROLIX 500 Unit with other medications, especially blood thinners.

ALPROLIX 500 Unit should be stored as per the manufacturer's instructions, typically in a refrigerator.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.